Andrew R. Clamp
Manchester Academic Health Science Centre(GB)University of Manchester(GB)Manchester University NHS Foundation Trust(GB)Cancer Research UK Manchester Institute(GB)The Christie NHS Foundation Trust(GB)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Intraperitoneal and Appendiceal Malignancies, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Copy number signatures and mutational processes in ovarian carcinoma(2018)445 cited
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial(2021)399 cited
- → Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials(2018)294 cited